The global non-Hodgkin’s lymphoma treatment market was valued at USD 13.44 Billion in 2024 and is expected to reach USD 26.94 Billion by 2034, growing at a CAGR of 7.20%. Market growth is driven by technological advancements and increased accessibility of treatment options worldwide. https://www.expertmarketresearch.com/reports/non-hodgkins-lymphoma-treatment-market